Bipartisan legislation introduced in the U.S. House of Representatives would make financial benefits and health insurance immediately available to people with terminal breast cancer.
Legislation introduced in Mississippi would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. In 2023, more than 2,610 people will be diagnosed with breast cancer and more than 470 will die of the disease in Mississippi alone.
Legislation introduced in Minnesota would financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. In 2023, more than 5,220 people will be diagnosed with breast cancer and more than 640 will die of the disease in Minnesota alone.
Legislation introduced in Virginia would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. In 2023, more than 7,810 people will be diagnosed with breast cancer and more than 1,150 will die of the disease.
Legislation introduced in Washington would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy.
Susan G. Komen has identified three areas where it will work in the 2023 and 2024 state and federal legislative sessions to enact laws so that where you live does not determine if you live.
Legislation introduced in New Mexico would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. Last year alone, more than 1,700 individuals were diagnosed with breast cancer and more than 290 died of the disease in New Mexico.
Susan G. Komen®, the world’s leading breast cancer organization, applauds Representative Brenda Shields (R-St. Joseph) for working with Komen to introduce legislation that would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. Last year alone, more than 5,560 individuals were diagnosed with breast cancer and more than 820 died of the disease in Missouri.
Susan G. Komen and Guardant Health have formed a new partnership to help improve breast cancer outcomes by including the input of patient advocates. These advocates, who serve as Susan G. Komen Advocates in Science, will provide a first-hand understanding of what matters most to patients in the development of research studies to find more effective ways to care for patients with early-stage breast cancer.
Susan G. Komen®, the world’s leading breast cancer organization, named Geoffrey M. Wahl, PhD, and Norman Wolmark, MD, FACS, FRCSC, two leading breast cancer researchers, as recipients of this year’s Brinker Awards, Komen’s highest scientific honor.
Susan G. Komen®, the world’s leading breast cancer organization, and GE Healthcare, a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, are partnering for the first time to support the Susan G Komen’s Metastatic Breast Cancer (MBC) Impact Series.
Susan G. Komen®, the world’s leading breast cancer organization, is expanding its screening and diagnostics program from nine cities to 12. Now, income-eligible residents from Dallas, Los Angeles, and Memphis also can access no-cost, breast cancer screening and diagnostic services. Atlanta, Chicago, Fort Worth, Houston, Madison, WI, Marshfield, WI, Philadelphia, Virginia Beach, and Washington D.C. are the other cities where the program is already operating.
Susan G. Komen® is awarding $21.7 million to fund 48 new research projects at 26 distinguished academic medical institutions in the U.S. that are focused on improving patient outcomes – particularly for people with the most aggressive breast cancers, or who have experienced a recurrence or metastasis.
A new study examining how to harness one’s immune system to eliminate metastatic breast cancer (MBC) tumors in the body is receiving a three-year $600,000 grant from Susan G. Komen®, the world’s leading breast cancer organization.
Susan G. Komen awarded a research grant to apply a new, first-of-its-kind tool that seeks to more accurately diagnose inflammatory breast cancer (IBC).
Susan G. Komen and Major League Baseball to celebrate moms on Mother's Day.
Susan G. Komen has appointed 10 world-renowned breast cancer researchers and two patient advocates to serve as advisors to the organization. They join a distinguished group of breast cancer researchers, clinicians and advocates who help guide Komen’s work so that people who have been diagnosed with breast cancer can live longer, better lives.
Findings from Study Led by Susan G. Komen Scholars Published in JAMA Oncology
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right